Mydecine Reports Positive Preclinical Results on MYCO-006 Short-Acting MDMA Analogues

Tue, Apr 25

Perspectives

According to Mydecine, MYCO-006 compounds can last one-third as long as MDMA, lasting around one to two hours vs the conventional six to eight hour duration of Gen-1 MDMA, with a four-fold onset increase. https://t.co/uGNfUVgUDs

2859

Mydecine Reports Positive Preclinical Results on the MYCO-006 Series of its Short-Acting MDMA Analogues VANCOUVER, British Columbia, April 24, 2023 (GLOBE NEWSWIRE) — Mydecine Innovations Group...

Discover